Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma
NCT02647112
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
1050
Enrollment
INDUSTRY
Sponsor class
Conditions
Bladder Cancer
Interventions
OTHER:
Bladder EpiCheck
Sponsor
Nucleix Ltd.